Shenzhen - Delayed Quote CNY
Shandong Sito Bio-technology Co., Ltd. (300583.SZ)
20.10
+0.84
+(4.36%)
At close: 3:04:40 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
986,056.17
970,601.33
1,279,783.09
1,312,111.84
1,202,622.70
Cost of Revenue
846,691.28
784,898.74
994,242.63
1,039,302.10
937,035.16
Gross Profit
139,364.89
185,702.59
285,540.46
272,809.75
265,587.55
Operating Expense
179,329.02
193,325.79
200,771.53
189,133.43
168,527.83
Operating Income
-39,964.13
-7,623.20
84,768.93
83,676.31
97,059.72
Net Non Operating Interest Income Expense
-32,762.03
-32,118.84
-35,468.18
-35,169.90
-28,915.76
Pretax Income
-140,583.81
-102,748.87
53,479.58
47,910.85
54,288.71
Tax Provision
-3,591.13
-1,420.61
4,932.43
5,445.14
18,502.62
Net Income Common Stockholders
-119,345.97
-88,766.73
45,603.99
41,967.41
36,205.36
Basic EPS
-0.64
-0.47
0.25
0.24
0.21
Diluted EPS
-0.64
-0.47
0.25
0.24
0.21
Basic Average Shares
196,328.79
188,865.39
182,415.96
174,864.23
170,378.17
Diluted Average Shares
196,328.79
188,865.39
182,415.96
174,864.23
170,378.17
Total Operating Income as Reported
-139,442.54
-102,062.69
32,738.80
49,224.85
55,972.88
Total Expenses
1,026,020.30
978,224.53
1,195,014.16
1,228,435.53
1,105,562.98
Net Income from Continuing & Discontinued Operation
-119,345.97
-88,766.73
45,603.99
41,967.41
36,205.36
Normalized Income
-41,465.79
-15,253.84
62,289.87
48,472.47
46,428.62
Interest Income
2,048.01
2,407.59
4,736.53
3,712.40
2,658.42
Interest Expense
29,255.81
30,853.02
37,658.71
36,886.03
30,210.76
Net Interest Income
-32,762.03
-32,118.84
-35,468.18
-35,169.90
-28,915.76
EBIT
-111,328
-71,895.86
91,138.29
84,796.89
84,499.48
EBITDA
-111,328
102,750.65
264,707.33
248,027.33
219,946.97
Reconciled Cost of Revenue
846,691.28
784,898.74
994,242.63
1,039,302.10
937,035.16
Reconciled Depreciation
--
174,646.51
173,569.04
163,230.44
135,447.49
Net Income from Continuing Operation Net Minority Interest
-119,345.97
-88,766.73
45,603.99
41,967.41
36,205.36
Total Unusual Items Excluding Goodwill
-79,921.73
-74,543.53
-18,381.17
-7,339.16
-15,509.03
Total Unusual Items
-79,921.73
-74,543.53
-18,381.17
-7,339.16
-15,509.03
Normalized EBITDA
-31,406.27
177,294.18
283,088.50
255,366.49
235,455.99
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,041.55
-1,030.64
-1,695.30
-834.11
-5,285.77
12/31/2021 - 1/9/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade